These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
417 related items for PubMed ID: 1382781
21. Ionotropic glutamate receptor types leading to adenosine-mediated inhibition of electrically evoked [3H]-noradrenaline release in rabbit brain cortex slices. von Kügelgen I, Späth L, Starke K. Br J Pharmacol; 1993 Dec; 110(4):1544-50. PubMed ID: 7508327 [Abstract] [Full Text] [Related]
22. Metabotropic and ionotropic excitatory amino acid receptor agonists induce different behavioral effects in mice. Laudrup P, Klitgaard H. Eur J Pharmacol; 1993 Nov 30; 250(1):15-22. PubMed ID: 7509749 [Abstract] [Full Text] [Related]
23. Cyclothiazide reverses AMPA receptor antagonism of the 2,3-benzodiazepine, GYKI 53655. Palmer AJ, Lodge D. Eur J Pharmacol; 1993 Jan 15; 244(2):193-4. PubMed ID: 7679352 [Abstract] [Full Text] [Related]
24. Electrophysiological evidence for the existence of NMDA and non-NMDA receptors on rat ventral tegmental dopamine neurons. Wang T, French ED. Synapse; 1993 Mar 15; 13(3):270-7. PubMed ID: 7684531 [Abstract] [Full Text] [Related]
25. 6-Cyano-7-nitroquinoxaline-2,3-dione as an excitatory amino acid antagonist in area CA1 of rat hippocampus. Blake JF, Yates RG, Brown MW, Collingridge GL. Br J Pharmacol; 1989 May 15; 97(1):71-6. PubMed ID: 2566354 [Abstract] [Full Text] [Related]
26. Substance P modulates glutamate-induced currents in acutely isolated rat spinal dorsal horn neurones. Randić M, Hećimović H, Ryu PD. Neurosci Lett; 1990 Sep 04; 117(1-2):74-80. PubMed ID: 1705317 [Abstract] [Full Text] [Related]
27. Glutamate stimulates glucagon secretion via an excitatory amino acid receptor of the AMPA subtype in rat pancreas. Bertrand G, Gross R, Puech R, Loubatières-Mariani MM, Bockaert J. Eur J Pharmacol; 1993 Jun 11; 237(1):45-50. PubMed ID: 7689469 [Abstract] [Full Text] [Related]
28. Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures. Kristensen BW, Noraberg J, Zimmer J. Brain Res; 2001 Oct 26; 917(1):21-44. PubMed ID: 11602227 [Abstract] [Full Text] [Related]
29. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy. Potschka H, Löscher W, Wlaź P, Behl B, Hofmann HP, Treiber HJ, Szabo L. Br J Pharmacol; 1998 Nov 26; 125(6):1258-66. PubMed ID: 9863655 [Abstract] [Full Text] [Related]
30. Characterization of YM90K, a selective and potent antagonist of AMPA receptors, in rat cortical mRNA-injected Xenopus oocytes. Okada M, Kohara A, Yamaguchi T. Eur J Pharmacol; 1996 Aug 15; 309(3):299-306. PubMed ID: 8874154 [Abstract] [Full Text] [Related]
31. Inhibitory effect of anti-seizure medications on ionotropic glutamate receptors: special focus on AMPA receptor subunits. Fukushima K, Hatanaka K, Sagane K, Ido K. Epilepsy Res; 2020 Nov 15; 167():106452. PubMed ID: 32911258 [Abstract] [Full Text] [Related]
32. Evidence for N-methyl-D-aspartate and AMPA subtypes of the glutamate receptor on substantia nigra dopamine neurons: possible preferential role for N-methyl-D-aspartate receptors. Christoffersen CL, Meltzer LT. Neuroscience; 1995 Jul 15; 67(2):373-81. PubMed ID: 7545793 [Abstract] [Full Text] [Related]
33. Excitatory amino acid receptors expressed in Xenopus oocytes: agonist pharmacology. Verdoorn TA, Dingledine R. Mol Pharmacol; 1988 Sep 15; 34(3):298-307. PubMed ID: 2901662 [Abstract] [Full Text] [Related]
34. AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h. Sheardown MJ, Suzdak PD, Nordholm L. Eur J Pharmacol; 1993 Jun 04; 236(3):347-53. PubMed ID: 7689464 [Abstract] [Full Text] [Related]
35. Antagonist pharmacology of kainate- and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-preferring receptors. Wilding TJ, Huettner JE. Mol Pharmacol; 1996 Mar 04; 49(3):540-6. PubMed ID: 8643094 [Abstract] [Full Text] [Related]
36. Amelioration of functional deficits from spinal cord trauma with systemically administered NBQX, an antagonist of non-N-methyl-D-aspartate receptors. Wrathall JR, Teng YD, Choiniere D. Exp Neurol; 1996 Jan 04; 137(1):119-26. PubMed ID: 8566203 [Abstract] [Full Text] [Related]
37. NBQX prevents contralateral but not ipsilateral seizure-induced cytotoxicity of kainate but not AMPA-reversal at high doses of NBQX. Lees GJ, Leong W. Neuroreport; 1994 Oct 27; 5(16):2153-6. PubMed ID: 7532455 [Abstract] [Full Text] [Related]
38. Contribution of spinal glutamatergic receptors to the antinociception caused by agmatine in mice. Gadotti VM, Tibola D, Paszcuk AF, Rodrigues AL, Calixto JB, Santos AR. Brain Res; 2006 Jun 06; 1093(1):116-22. PubMed ID: 16765330 [Abstract] [Full Text] [Related]
39. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release. I. Location on axon terminals and pharmacological characterization. Pittaluga A, Raiteri M. J Pharmacol Exp Ther; 1992 Jan 06; 260(1):232-7. PubMed ID: 1370540 [Abstract] [Full Text] [Related]
40. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia. Sheardown MJ, Nielsen EO, Hansen AJ, Jacobsen P, Honoré T. Science; 1990 Feb 02; 247(4942):571-4. PubMed ID: 2154034 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]